Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), bought 4,200 shares at $85.01 ($357K) on 2020-09-02, disclosed to the SEC on 2020-09-11.
Scheduled purchase ($357k) by Chief Commercial Officer.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |